Treatment of Hyperpyrexia and in the Pediatric Emergency Department (FEVER_ED)
NCT ID: NCT06194383
Last Updated: 2024-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
160 participants
OBSERVATIONAL
2023-12-22
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management and Outcome of Fever in Children in Europe
NCT05221437
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
NCT07074912
Adding a Second Drug for Febrile Children Treated With Acetaminophen
NCT00389272
Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine
NCT02430272
Antipyretics for Preventing Recurrences of Febrile Seizures
NCT00568217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fever (T \> 38°C) with/without associated symptoms, treated with standard antipyretic drugs orally (paracetamol, ibuprofen or paracetamol/ibuprofen combination)
* who have expressed their consent to participate in the study.
Exclusion Criteria
* patients who did not express consent to participate in the study
6 Months
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fondazione Policlinico Univers
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ID6119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.